Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/30/2012 | CN101148668B Clone for pork generation character related gene BTG1 of pig and application thereof in pig molecule mark auxiliary selection |
05/30/2012 | CN101148667B Preparation and use for affinity human albumin nucleic acid aptamer |
05/30/2012 | CN101148666B Nucleic acid adapter with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof |
05/30/2012 | CN101146818B Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
05/30/2012 | CN101107354B Method for producing a compound of interest in a filamentous fungal cell |
05/30/2012 | CN101024827B Expression, purification and crystallization of urokinase catalyst structure domain mutant |
05/30/2012 | CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
05/30/2012 | CN101002549B Transgenic non-human animals capable of producing heterologous antibodies |
05/29/2012 | USRE43425 Mutant prenyl diphosphate synthase |
05/29/2012 | US8188351 Plants and seeds of hybrid corn variety CH174075 |
05/29/2012 | US8188346 Cotton variety ST 4498B2RF |
05/29/2012 | US8188345 Cotton variety ST 5458B2RF |
05/29/2012 | US8188344 Cotton variety FM 9180B2F |
05/29/2012 | US8188343 Soybean variety XB48Q10 |
05/29/2012 | US8188342 Soybean cultivar 8235453 |
05/29/2012 | US8188341 Soybean cultivar 82264565 |
05/29/2012 | US8188340 Lettuce cultivar Manitou |
05/29/2012 | US8188339 Sugar and lipid metabolism regulators in plants IV |
05/29/2012 | US8188338 Isolated nucleic acid fragments and recombinant constructs; plant cells, transgenic seeds, progeny plants |
05/29/2012 | US8188337 Cloning of cytochrome p450 genes from Nicotiana |
05/29/2012 | US8188336 Rice and products thereof having starch with an increased proportion of amylose |
05/29/2012 | US8188334 Injecting drosophila embryos |
05/29/2012 | US8188269 Functionalized compositions for improved immobilization |
05/29/2012 | US8188264 RNAi mediated knockdown of NuMA for cancer therapy |
05/29/2012 | US8188263 Modified siRNA molecules and uses thereof |
05/29/2012 | US8188260 Versatile acylation catalytic RNAs and uses thereof |
05/29/2012 | US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
05/29/2012 | US8188254 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
05/29/2012 | US8188253 Penaeidin gene promoters in tiger shrimp and applications thereof |
05/29/2012 | US8188252 Rad51 derived cancer cell specific promoters for targeted anti-cancer therapy |
05/29/2012 | US8188249 Nucleic acid molecules encoding antibodies to M-CSF |
05/29/2012 | US8188248 Nucleic acids encoding interleukin-12P40 variants with improved stability |
05/29/2012 | US8188246 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
05/29/2012 | US8188244 Carcinoembryonic antigen fusions and uses thereof |
05/29/2012 | US8188230 Method for recombinant microorganism expression and isolation of collagen-like polypeptides |
05/29/2012 | US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
05/29/2012 | US8188226 High activity growth factor mutants |
05/29/2012 | US8188214 Brachyury polypeptides and methods for use |
05/29/2012 | US8188062 Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA |
05/29/2012 | US8188059 Compounds and methods for modulating expression of GCGR |
05/29/2012 | US8188057 Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases |
05/29/2012 | US8188056 Utilizing nucleic acid expression constructs that are delivered into a subject and express stable therapeutic proteins in vivo |
05/29/2012 | US8188040 FGF21 mutants and uses thereof |
05/29/2012 | US8188039 VEGF-D mutants and their use |
05/29/2012 | US8188036 Genes encoding novel proteins with pesticidal activity against coleopterans |
05/29/2012 | US8187884 Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody |
05/29/2012 | US8187883 Method and system for delivering nucleic acid into a target cell |
05/29/2012 | US8187882 Regenerating transgenic crop plants from meristematic tissues cultured in dikegulac; enhancing soybean and cotton production |
05/29/2012 | US8187872 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein |
05/29/2012 | US8187871 Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond |
05/29/2012 | US8187870 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof |
05/29/2012 | US8187859 Transformed yeast comprising defective urea carboxylase-allophanate hydrolase gene and reduce nitrogen catabolite repression for use as tool in fermentation of alcoholic beverages |
05/29/2012 | US8187856 Recombinant halohydrin dehalogenase polypeptides |
05/29/2012 | US8187855 Large-scale production of soluble hyaluronidase |
05/29/2012 | US8187854 Lipase variants |
05/29/2012 | US8187846 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors |
05/29/2012 | US8187845 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors |
05/29/2012 | US8187842 Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals |
05/29/2012 | US8187840 Microorganism producing inosine and method of producing inosine using the same |
05/29/2012 | US8187836 Mammalian expression vectors and uses thereof |
05/29/2012 | US8187835 Using methylobacterium as bioreactor for production preferential biopolymers |
05/29/2012 | US8187823 Modulation of neuroglia-derived BDNF in the treatment and prevention of pain |
05/29/2012 | US8187805 Method of detecting nucleic acid and utilization thereof |
05/29/2012 | US8187610 Streptococcus equi strain |
05/29/2012 | US8187600 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
05/29/2012 | US8187597 Combination therapy for the treatment of ocular neovascular disorders |
05/29/2012 | US8187590 Probiotic, lactic acid-producing bacteria and uses thereof |
05/29/2012 | US8187587 Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme |
05/29/2012 | US8187586 Methods of inducing apoptosis in hyperproliferative cells |
05/29/2012 | CA2617803C Nucleotide sequences encoding insecticidal proteins |
05/29/2012 | CA2616914C Egfr-binding antibody |
05/29/2012 | CA2538863C Selection system containing non-antibiotic resistance selection marker |
05/29/2012 | CA2516022C Model for studying the role of genes in tumor resistance to chemotherapy |
05/29/2012 | CA2514584C Peptide inhibitors of toxins derived from ll-37 |
05/29/2012 | CA2487846C Method, composition and kit for antigenic binding of norwalk-like viruses |
05/29/2012 | CA2478616C Use of adenoviruses mutated in the va genes for cancer treatment |
05/29/2012 | CA2476892C Mononucleotide repeats microsatellite markers for detecting microsatellite instability |
05/29/2012 | CA2469623C Composition for the preservation of viruses |
05/29/2012 | CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
05/29/2012 | CA2449264C Method for generating diversity |
05/29/2012 | CA2440767C Novel neurotrophic factors |
05/29/2012 | CA2431321C Monoclonal antibodies to human immunodeficiency virus and uses thereof |
05/29/2012 | CA2408786C Retroviral vectors comprising an enhanced 3' transcription termination structure |
05/29/2012 | CA2406191C Cestrum yellow leaf curling virus promoters |
05/29/2012 | CA2403817C Methods of modulating hair growth |
05/29/2012 | CA2403327C Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
05/29/2012 | CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
05/29/2012 | CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
05/29/2012 | CA2379388C Immunoglobulin fusion proteins |
05/29/2012 | CA2365099C Transgenic plants that are resistant to a broad spectrum of pathogens |
05/29/2012 | CA2361292C A novel chimeric protein for prevention and treatment of hiv infection |
05/29/2012 | CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
05/29/2012 | CA2341340C Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
05/29/2012 | CA2338005C Peptide antagonists of zonulin and methods for use of the same |
05/29/2012 | CA2329148C Specific binding proteins for treating canine allergy |
05/29/2012 | CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
05/29/2012 | CA2280736C Methods for modulating hematopoiesis and vascular growth |
05/29/2012 | CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use |
05/29/2012 | CA2251604C Human hematopoietic stem and progenitor cell antigen and methods for its use |
05/24/2012 | WO2012068540A2 Neutralizing anti-ccl20 antibodies |